Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge acts as lead advisor to EQT in connection with its acquisition of Life Sciences Partners
Mandate

Vinge acts as lead advisor to EQT in connection with its acquisition of Life Sciences Partners

November 10, 2021 M&A Banking and Finance EU, Competition and Regulatory Capital Markets and Public M&A

Vinge acts as lead advisor to EQT AB in connection with its acquisition of Life Sciences Partners, a leading European life sciences venture capital firm with approximately EUR 2.2 billion of assets under management

LSP, headquartered in Amsterdam, the Netherlands, is a venture capital firm that invests in innovative companies with strong scientific and clinical rationale across several life sciences strategies. LSP was founded in 1998 and today is one of Europe’s largest and most experienced life sciences investment firms. LSP employs a large number of professionals across its offices in Amsterdam, Munich and Boston. Over the past two decades, LSP has invested in over 150 life sciences companies, generated strong returns, and built a top-performing life sciences franchise. As part of EQT, the LSP team will be able to continue to operate in the same successful manner as they have been operating over the past two decades.

EQT AB will acquire 100 percent of the LSP management companies and 20 percent of the right to carried interest in select LSP funds. In addition, EQT AB will be entitled to 35 percent of the carried interest of future funds. The upfront consideration amounts to EUR 450 million (on a cash- and debt free basis) comprising of 25 percent cash and 75 percent EQT AB publicly traded shares.

Vinge’s team consisted of Christina Kokko, Karl Klackenberg and Milad Kamali (M&A), Sofie Bjärtun (Equity Capital Markets), Emma Johansson and Johan Wahlbom (Competition) and Emma Stuart-Beck and Caroline Krassén (Regulatory) and Ellinor Gyllenhammar (VDR Expert). Vinge has advised EQT together with Debevoise & Plimpton LLP (Investment Funds) and Loyens & Loeff (Dutch law)

Related

Vinge advises Humana in its acquisition of Team Olivia Norge AS

Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Care Holding AS ("Humana Norway") has entered into an agreement to acquire Team Olivia Norge AS for a purchase price of million SEK 341 on a cash- and debt-free basis.
May 17, 2024

Vinge advises Stendörren in connection with issuance of green capital securities and tender offer

 Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green subordinated and perpetual capital securities in an amount of SEK 300 million (within a framework of SEK 400 million) and its parallel tender offer in respect of its previously issued capital securities.
May 17, 2024

Vinge has advised Stockholm Exergi AB in connection with the conclusion of a permanent carbon removal agreement with Microsoft, the world’s largest to date

 Vinge has advised Stockholm Exergi in connection with the conclusion of a permanent carbon removal agreement with Microsoft, covering 3.33 million tonnes of permanent carbon removals from bio-energy with carbon capture and storage (BECCS) at Värtan, Stockholm. The agreement is the world’s largest permanent carbon removal deal to date.
May 16, 2024